Paclitaxel, Carboplatin and Low Dose Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer, Phase II

Grants and Contracts Details

StatusFinished
Effective start/end date10/9/021/31/15

Funding

  • Bristol Myers Squibb Company: $452.00